shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Sep 18th - 22nd Annual Day in Applied Psychoanalysis - Strangers in a Virtual Land: The Impact of Disembodied Relatedness on Psychic Development and the Sense of Self [Between Hours: Interdisciplinary Dialogues, Applied Psychoanalysis Programme of the Toronto Psychoanalytic Society]
Sep 23rd - Extension COURSE ONE - Lacan from the Beginnings [tps&i]
Sep 26th - Extension COURSE THREE - Discussing Netflix Series with Psychoanalysts [tps&i]
Oct 1st - ISSTD Toronto 2021 - Changing Landscapes: Transforming the Way We Understand and Treat Complex Trauma [ISSTD]
Oct 5th - Extension COURSE TWO - Understanding of Work Groups Through the Psychoanalytic Lens [tps&i]
schools agencies and other institutional orders (click here)
Now open for browsing 12-6 Mon-Sat and 12-5 Sunday for three people at a time. Pickups still from 9 to 6, Monday to Saturday. Free shipping across Canada for orders over $100. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Clinical Handbook of Psychotropic Drugs, 24th Edition
Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, and J. Joel Jeffries
Hogrefe Publishing / Spiral Bound / 2021-09-01 / 0889375933
Psychopharmacology
price: $130.95 (may be subject to change)
432 pages
Not in Stock, usually ships in 3-6 business days

The classic reference for psychotropic medications

The Clinical Handbook of Psychotropic Drugs and the Clinical Handbook of Psychotropic Drugs for Children and Adolescents are independent and unbiased practical tools for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals. They are packed with unique comparison charts that support effective medication decisions. Color-coding and instantly recognizable icons enable quick access to succinct, bulleted information on all classes of medication, their on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in special populations, nursing implications, and much more. Sections on Natural Health Products, Unapproved Treatments, ECT, BLT, and rTMS are included. Patient and caregiver information sheets are provided as printable PDF files

New in this edition:

• Neuroscience-based nomenclature – added to product availability tables
• Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso); also updates to SSRI use in pregnancy and antidepressant augmentation strategies
• Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment
• Mood stabilisers chapter sections on lithium and anticonvulsants extensively revised
• New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta (lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection)
• Breaking news: includes viloxazine (Qelbree), the first new drug for ADHD in children & adolescents approved by FDA in many years

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / 12-5 Sun (EST)

search
Click here to read previous issues.
authors
Bezchlibnyk-Butler, Kalyna
Jeffries, J Joel
Procyshyn, Ric M
other lists
Hogrefe Publishing
Psychopharmacology
September 2021 New Arrivals